Your search for medicaid returned 851 results

Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.

The time to sustained alleviation of COVID-19 symptoms was not significantly shorter with nirmatrelvir-ritonavir versus placebo.

A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.

Assisted living communities in New Jersey continue to face significant staffing challenges that compromise infection control effectiveness, according to a recently released report from Montgomery McCracken...

No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.

Lower portal activity was linked to older age, female sex and for Hispanic/Latinx, non-Hispanic Black and other race patients.

New guidance issued Friday by the US Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days.

Compared with those without COVID-19, similar deficits were seen for those in whom symptoms resolved in less than four or at least 12 weeks.

Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.

Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.